Go to deals
Consumer & Retail | Healthcare

Merck Animal Health has acquired a controlling stake in Vallée S.A.

Merck Animal Health has acquired a controlling stake in Vallée S.A.

Merck Animal Health, known as MSD outside the USA and Canada, is the global animal health business unit of Merck. Through its commitment to the Science of Healthier Animals™, Merck Animal Health offers veterinarians, farmers, pet owners and governments a wide range of veterinary pharmaceuticals, vaccines and health management solutions and services. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets.

Vallée was founded in 1961 in Uberlândia, State of Minas Gerais, as a company dedicated to the production of vaccines for foot-and-mouth disease. Vallée is one of the largest animal health companies in Brazil, with a diversified product offering, including vaccines, antiparasiticides, supplements, therapeutic, reproduction and nutritional products for both production animals and pets.

One of Oaklins’ teams in Brazil acted as the sole financial advisor for Merck Animal Health in this transaction.

Parties

Talk to the deal team

Richard Rainer

Managing Partner
São Paulo, Brazil
Oaklins Olimpia Partners

Victor Andreoli

Partner
São Paulo, Brazil
Oaklins Olimpia Partners

Irajá Guimarães

Partner
São Paulo, Brazil
Oaklins Olimpia Partners

Related deals

OBI Group has acquired the OBI and individual DIG stores from Migros
Consumer & Retail

OBI Group has acquired the OBI and individual DIG stores from Migros

As part of a strategic review, Migros has decided to divest its DIY business, which included several “Do It + Garden” and “OBI” locations. Migros had operated the Swiss OBI stores as a franchisee. In OBI Group Holding, Migros has found the ideal partner to ensure continuity for both its customers and employees.

Learn more
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Healthcare

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

Learn more
Afric Phar has been acquired by Pharma Capital
Healthcare

Afric Phar has been acquired by Pharma Capital

Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.

Learn more